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Abstract
Palliative care is defined as a specialty of medicine that improves the quality of life of patients
and family members facing a life-threatening illness, by providing early detection and prevention
of pain, psychological, and other physical struggles. Patients diagnosed with diseases such as
congestive heart failure or lung disease will face an ongoing list of problems that impacts their
quality of life, yet most do not receive the proper tools to manage their disease until the last
stages of their life. Implementing palliative care at the initial diagnosis of a chronic
cardiothoracic disease improves precision of patient-centered goals, symptom management, and
overall quality of life for the patient.
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Implementing Palliative Care Pre-Cardiothoracic Transplant
Cardiothoracic Diseases
The diagnosis of a chronic cardiothoracic disease such as congestive heart failure (CHF),
or lung diseases like idiopathic pulmonary fibrosis (IPF) or chronic obstructive pulmonary
disease (COPD), requires a patient to decide treatment options that often focus on life-prolonging
measures, even cardiothoracic transplant. With the diagnosis of a chronic illness, medical
specialties such as cardiology, pulmonology, and cardiothoracic surgery are immediately
employed. Under most circumstances, palliative care is rarely integrated until the patient's status
is deteriorating or there is a failure to thrive.
The World Health Organization (2018) defines palliative care as "an approach that
improves the quality of life of patients and their families facing the problem associated with lifethreatening illness, through the prevention and relief of suffering by means of early identification
and impeccable assessment and treatment of pain and other problems, physical, psychosocial and
spiritual. Palliative care provides relief from pain and other symptoms, emphasizes advanced
care planning and medical treatment based on patient wishes, and uses an interdisciplinary
approach to address all needs of the patient and family. Palliative care is split into eight domains
that focus on 'whole person care' that acknowledges nonmedical facets of suffering when
diagnosed with a serious or life-threatening illness (Anderson, Frazer, & Schellinger, 2018).
These domains ensure that a patient is taken care of physically, psychologically, socially,
spiritually, culturally, ethically, and at the time of death, while simultaneously ensuring that all
necessary medical specialties are involved in patient care.
Integrating palliative care at the initial diagnosis of a life-threatening cardiothoracic
disease would allow treatment options to be based on patient-centered goals of care, focus on
symptom management, and improve quality of life for the patient. Since heart failure impacts
nearly 6 million people in the United States and remains one of the leadings causes of
hospitalization and health care expenditures it is important to focus on heart failure and how
these patients' lives will be impacted (Tanner, Fromme, & Goodlin, 2011).
In order to recommend an integrated care model for a patient with the diagnosis of a
chronic disease, it is important to understand how symptoms will impact the patient, how
symptoms can be managed, and what can be done to optimize a patient's quality of life based on
their personal goals and the domains of palliative care.
Congestive Heart Failure
Congestive heart failure is defined as the inability of the heart to keep up with the
demands on it, with failure of the heart to pump blood with normal efficiency. The heart is then
unable to provide adequate blood flow to organs such as the brain, kidneys, and liver. Heart
disease and CHF are difficult illnesses due to their complex symptom burden. CHF symptoms
include: dyspnea, cardiac asthma, poor blood circulation, edema, and enlargement of the heart
that leads to weakness, decreased blood flow to accessory organs, dizziness, and a decrease in
overall function. These symptoms prevent patients from performing daily activities as they once
did and often times impacts quality of life.
Lung Disease
Lung disease is defined as any problem in the lungs that prevents a patient from working
properly, whether it may be an airway disease (chronic obstructive pulmonary disease), lung
tissue disease (cystic fibrosis), or lung circulation disease (pulmonary hypertension). Symptoms
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of lung disease often include: coughing, wheezing, frequent respiratory infections, fatigue, and
poor blood circulation. Mozes (2017) reports from 1980 through 2014, more than 4.6 million
Americans died from a range of chronic respiratory illnesses (Mozes, 2017). The risk of death
from chronic respiratory diseases rose 31% over the past 35 years and nearly 7% of all deaths in
America are due to chronic respiratory diseases (Mozes, 2017). Factors for the increased rates
are multifactorial but the significant increase in rates suggests that greater attention be paid to
lung diseases. Currently, lung transplant candidates are rarely referred to palliative care unless
they are deemed ineligible for transplant. End of life care is often aggressive and not based on
comfort (Colman, Singer, Barua, & Downar, 2015).
Commonly, palliative care is associated with hospice and dying. Physicians often make
this assumption and postpone palliative care intervention as long as possible. However, the
symptoms and statistics of chronic cardiothoracic disease suggest that integrating palliative care
with cardiothoracic disease in its early stage is necessary as patients often have prolonged
periods of stability between exacerbations of their symptoms (Tanner, Fromme, & Goodlin,
2011). Integrating palliative care at the initial diagnosis of a chronic cardiothoracic disease
improves precision of patient-centered goals, symptom management, and overall quality of life
for the patient.
Choices After Diagnosis
After being diagnosed with cardiovascular disease or idiopathic pulmonary fibrosis, for
example, the patient and family is often overwhelmed with information and the potential
treatment options following their diagnosis. Subsequent heart disease treatment options often
include procedures such as coronary artery bypass graft, insertion of ICD pacemakers,
ventricular assist devices, extracorpeal membrane oxygenation (ECMO), heart transplant or
potentially the use of only medications such as beta-blockers or diuretics. These treatment
options range from mild to highly aggressive depending on the condition and wishes of the
patient and the family.
Lung disease follows a similar pattern of mild to aggressive treatment options. Common
treatment options include breathing treatments and antioxidants to slow the rate of lung decline
in hopes of improving symptoms such as dyspnea, hypoxia, and weakness. Although those
treatments may postpone the rate at which lung disease progresses, "lung transplantation remains
the only treatment for most non-malignant end-stage lung disease" with the transplant candidates
carrying a high symptom burden physically and psychologically (Colman, Singer, Barua, &
Downar, 2015).
Medical facilities traditionally recommend heart and lung transplantation when other
medical treatments no longer help. Medical programs currently believe the right time to proceed
with transplantation is when it is felt that the patient would live longer with a transplant than
with the heart or lung disease. Although this seems intuitive we must consider the treatment
imperative- "defined as the perceived need by physicians and patients to provide interventions.
The treatment imperative is driven by physicians' desires to offer treatment and patients feeling
bound to not refuse treatment" (Santivasi, Strand, Mueller, & Beckman, 2017). Doctors are
required to honor the Hippocratic oath in their practice; to do no harm and to treat the ill to the
best of one's ability. Physicians are educated and trained to save patients' lives. The quality of
life may at some point be compromised at the cost of prolonging someone's life. Patients feel
intrigued to try new experimental surgeries or treatments that are considered life-prolonging but
often times forget their personal wishes and goals of care or are unaware of the side effects.

PALLIATIVE CARE PRE-CARDIOTHORACIC TRANSPLANT

6

Physicians take their oath to save and heal, but they may forget that they should do what is best
for the patient, which may or may not be performing surgery or providing life-prolonging
treatment. Similar to the treatment imperative is the organ transplant imperative which is "the
perceived obligation to proceed with transplant and avoid end-of-life planning even in situations
where the patient is experiencing poor quality of life and low likelihood of meaningful survival"
(Santivasi, Strand, Mueller, & Beckman, 2017). With considerations of the treatment and organ
transplant imperatives, it is important to have conversations regarding goals of care with the
patient and family. The conversation should not occur once and be forgotten about. Goals of care
and expectations from the patient should be addressed at the initial diagnosis and continue as the
patient progresses with their disease to ensure that treatment, or lack of treatment, is what is best
for the patient.
Chronicity of Disease
Cardiothoracic diseases are complex due to their chronic nature with a slow and steady
decline in function. Patients dealing with a chronic, or life threatening illness will experience
what Robin Rone (2011) refers to as the four components of pain, better explained in figure 5
(Rome, Luminais, Bourgeois, & Blais, 2011). The four components include physical symptoms,
anxiety over the time to come, interpersonal problems, and not accepting that death may be
approaching. Patients dealing with heart failure face a shortened lifespan and a chronic decline in
function that may not be visible until the onset of an acute exacerbation (Tanner, Fromme, &
Goodlin, 2011). It is difficult to prepare for and treat these acute bouts of CHF or lung disease
without palliative care and the advanced care planning the specialty provides. When an acute
event occurs, sudden decisions by the patient or patient's family member are made during
stressful periods. These decisions often do not focus on the patient's goals of care but only what
is necessary in the moment. In these circumstances difficult decisions are often postponed to
focus on the present medical issue.
Patients awaiting a transplant experience high levels of anxiety due to the uncertain
amount of time on the organ donor list. The demand for organs far exceeds the supply, causing
patients to be on waitlists for years potentially. As of October, 2018 the Gift of Life states 156
Michigan residents are awaiting heart transplants and 99 Michigan residents are waiting for
lungs. While waiting for a transplant, a patient's condition may wax and wane so it is important
to address goals of care and patient wishes even before a transplant because patients may never
reach the destination of a transplant. Discussing goals of care prior to transplant helps navigate
the uncertain territory of the waitlist.
Patients should be guided to appreciate that certain life-sustaining measures such as
extracorpeal cardiopulmonary life support (ECLS) are not life saving but life prolonging until the
next option arrives. ECLS is a variation of cardiopulmonary bypass that maintains oxygenation
for days to weeks in patients with life threatening respiratory or cardiac failure. Patients may not
understand they may not be guaranteed a transplant once placed on the list, and even if the
patient receives a transplant, it may not be beneficial. Aggressive end of life care such as ECLS
is associated with worse patient quality of life and higher rate of anxiety in bereaved family
members (Colman, Singer, Barua, & Downar, 2015). Even when patients with idiopathic
pulmonary fibrosis are not being considered for transplant, a high proportion die in the ICU, with
relatively few are seen by a palliative care specialist.
Discussing goals of care and expectations of treatment prior to transplant helps medical
providers and patients align their expectations and base treatment options accordingly to provide
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a better understanding of the uncertain road associated with cardiothoracic disease and
transplantation.
Lack of Palliative Care Education
Patients often experience unclear expectations when a cardiothoracic transplant is
suggested as mentioned above. Time on the waitlist may take a toll on the patient and their
family. However, even when the relief of palliative care (PC) is offered when the patient begins
their chronic deterioration, a negative connotation is associated with the term. Palliative care is
too closely associated with hospice and dying in today's society. When a patient or family
member hears the suggestion of palliative care, they immediately associate the term with hospice
and dying in the near future, or do not know what PC entails. Figure 2 evaluates how aware
consumers are of the term palliative care; 92% are unfamiliar with the actual purpose of PC. It
should be made clear that palliative care and hospice are separate specialties of medicine with
similar goals including improving and, or maintaining the patient's quality of life (QOL).
Barriers to early evaluation of care preferences in lung transplant patients include the
perception that these discussions would disqualify patients from disease-directed therapies. With
this in mind, some providers and patients believe that PC is incompatible with transplantation
and that palliative treatments should be held until the patient's final hours to not ruin the chance
for transplant (Santivasi, Stand, Mueller, & Beckman, 2017). Physician focus groups showed
that physicians are often very hesitant to recommend palliative care as anything other than "end
of life care" or "comfort care", which would technically be considered hospice care, even though
physicians are not making this distinction (McInturff, Harrington, 2011). A survey of transplant
centers also indicated that patients believed if they engaged in palliative care they would feel
abandoned, or that their quality of care would be insufficient (Santivasi, Stand, Mueller, &
Beckman, 2017). In addition, patients expressed a concern with opioid dependency in association
with palliative care, although this has been proven not to be an issue (Colman, Singer, Barua, &
Downar, 2015). The lack of palliative care education amongst patients and providers alike makes
it difficult to suggest palliative care as a method of improving quality of life. Thus, an issue is
created where a trigger event must occur in order to initiate palliative care when the patient is in
their final stages of life, "perpetuating the false dichotomy of palliative care versus (rather than
palliative care plus) life-prolonging therapy" (Kavalieratos et al., 2017). It has been suggested
that using different terms when describing palliative care may be beneficial. For example, using
terms such as 'serious illness' instead of 'terminal illness' gives the patient hope that there is still
opportunity in the face of chronic illness. Education plays a large role in the acceptance and
integration of palliative care into everyday medicine. Quality of life can be improved for both
patients and families with a better understanding of palliative care.
General Benefits/ Purpose of Palliative Care
Palliative care is an interdisciplinary approach and clinical subspecialty that focuses on
improving QOL and reducing suffering experienced among patients with serious illness and their
families (Kavalieratos et al., 2017). To be clear, quality of life is the concept used when
discussing the implications of a serious medical condition. Doctors, family members, and others
can have an opinion on the patient's quality of life, but only the patient themselves are able to
truly determine their quality of life and what it would look like. One person may only care to be
self-sufficient as long as possible, while another may want to walk their daughter down the aisle
and be happy with whatever happens subsequent to that event. Each person has different goals
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and this makes quality of life multidimensional and very personal. Quality of life considers
physical, social, psychological, and spiritual wellbeing ("Quality of Life," 2012). Symptom
burden heavily dictates quality of life. To understand the magnitude of heart failure, it has been
stated that "advanced heart failure patients face a symptom burden comparable to that of
advanced cancer patients" (Tanner, Fromme, & Goodlin, 2011).
Management of Complex Symptom Burden. Palliative care puts emphasis on symptom
and pain management through medications and therapies that primary physicians would often not
consider. PC is able to manage complex symptom burden experienced by chronic heart and lung
disease patients. LVAD patients experience bleeding, infection, device thrombosis, and
cerebrovascular events that can negatively impact their QOL and place a large burden on family
members, physically and psychologically. Joint Commission and Centers for Medicare and
Medicaid Services (CMS) determined that PC should be incorporated into LVAD destination
therapy (Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman, 2017). Patients in end-stage
lung disease awaiting transplant experience physical, psychological, and emotional symptoms
including dyspnea, cough, anxiety, depression, and insomnia (Freeman et al., 2016). The
integrative approach PC provides would help manage symptoms and propose new ways to treat
complex symptoms.
Economic Relief. Along with the physical and psychological stress heart failure and lung
disease place on patients and families, there is also a large financial burden associated with these
diseases. Heart failure management places a large financial burden on families, health care
systems and society. Dio Kavalieratos states that "direct medical costs of HF are projected to be
>$77 billion by 2030, a 215% increase from current spending" (Kavalieratos et al., 2017). In
part, the massive expense can be attributed to recurring hospital admission associated with lack
of advanced care planning in HF and lung disease patients. Although doctors and patients tend to
avoid end of life (EOL) conversations and the possibility of death, patients who did engage in
these conversations had enhanced hope (Nakagawa, Yuzefpolskaya, Colombo, Naka, &
Blinderman, 2017). Patients who expressed their wishes under PC support would be able to
minimize unncecessary hospitalizations, thus decreasing costs and excess stress.
Improved Patient Outcomes. Palliative care is able to manage a complex symptom
burden associated with heart failure and lung disease, as well as improve patient outcomes. A
2010 study reported that lung cancer patients receiving early palliative care had less depression,
improved quality of life, and survived 2.7 months longer (Center to Advance Palliative Care). A
large proportion of end-stage lung disease patients (lung transplant candidates and recipients in
particular) die in a critical care environment, receiving aggressive care that is not focused on
comfort (Colman, Singer, Barua, & Downar, 2015). Palliative care would help to direct the
patient's medical care in the direction the patient and family deemed best. Institutions such as the
American College of Chest Physicians (ACCP) and American Thoracic Society (ATS) have both
emphasized the importance of palliative and end of life care (EOLC) for symptomatic patients
with pulmonary disease at any stage of illness (Colman, Singer, Barua, & Downar, 2015).
When to Begin Palliative Care
Introducing the topic of palliative care and the conversation of advanced care planning is
often one of the more difficult tasks doctors admit to in their practice, quite possibly a reason
palliative care is underutilized. New studies have suggested that the best way to manage heart
failure symptoms is to treat the underlying heart failure condition (e.g., relieving dyspnea by
addressing fluid overload) (Kavalieratos et al., 2017). The approach mentioned is an example of
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how heart failure and palliative care can interface in the early stages of a diagnosis to help
alleviate a patient's symptom burden and worries of their disease. At the initial diagnosis of heart
or lung disease, prognostication should be used to have clear algorithms and checklist in place to
manage care following diagnosis and determine if a patient is ready for a cardiothoracic
transplant. Included on the initial checklist should be the consult of palliative care. In this
manner, the PC team is able to meet with the patient, discuss goals of care, possible treatment
plans reflecting those goals or care, and support to patients deciding if cardiothoracic transplant
is in the patient's best interest. The use of such checklists could alleviate the transplant
imperative, unnecessary stress, and hospital visits for the patient.
In addition to using checklists and algorithms to standardize when patients should begin
palliative care, PC has shifted to outpatient consultations that would allow early integration of
services. Outpatient clinics suggest that a patient is still battling with a disease, but symptoms
have not progressed far enough to require hospitalization; this timing provides "an ideal
opportunity to integrate palliative care into a transplant program" (Wentlandt et al., 2016) The
patient and family member may feel less overwhelmed outside of a hospital where they feel they
may be dying. Outpatient palliative care consultations allow clear conversations to be made, with
the intent of advanced care planning and discussion of the realistic options ahead
The Transplant Palliative Care Clinic (TPCC) in Toronto, Canada is an outpatient clinic
that takes patients with any advanced disease as evaluated by the transplant program, and
performs palliative care consults with no limitation on prognosis, status on the waiting list, or
being pre- or post-transplantation (Wentlandt et al., 2016). The initial consultation lasts about 6090 minutes, includes a chart review, history, and assessment. Additionally, a symptom
assessment survey is completed at each appointment, with additional referrals being made as
necessary. The TPCC is allowing patients to have a patient- centered care plan that manages
symptoms and allows an integrative approach to be made regardless of the patient's progression
in their disease. The patient's status on the wait list is not compromised because of their PC
assistance as patients and physicians often fear- the only difference is the patient's QOL is
improved with palliative care consultations (Wentlandt et al., 2016). Figure 3 suggests starting
palliative care at the initial diagnosis and tailoring the patient's treatment to fit their goals, which
may change as the disease progresses. Table 1 provides insight into the timing related to
referring a patient to primary palliative care, or specialized palliative care resources. Primary PC
should be initiated at the initial diagnosis of cardiothoracic disease and as symptoms progress as
shown in the table, specialized care can be escalated (Kavalieratos et al., 2017).
Integration of Palliative Care
Saying that palliative care is important and worthy is not enough. The challenge remains
in how PC is integrated, and how it will supplement chronic disease and/or a potential
cardiothoracic transplant. Accepting the outlook that palliative care is 'preparedness planning' for
patients who are focused on improving shifts the connotation away from dying. It has been
suggested by Dr. Craig Tanner that preparedness planning should be proposed at the initial
diagnosis of heart failure (Tanner, Fromme, & Goodlin, 2011). In an effort to do this, palliative
care has been integrated in outpatient clinics, as mentioned previously. Additionally,
interdisciplinary primary care models for older adults with chronic illnesses are now of particular
interest. Four features of a care model trialed by Washington University's Care Coordination
Program included: comprehensive assessment of the patient's health conditions, treatments,
behaviors, risks, supports and resources, evidence-based care planning and monitoring to meet
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the patient's health related needs and preferences, promotion of patients' and family caregivers'
active engagement in care, and coordination and communication among all professionals
engaged in a patient's care (McCarthy, Ryan & Klein, 2015). Integrating a care model of this
nature offers to achieve the "triple aim" that reduces costs while improving the patient's health
and care experiences. A high need patient in this context would be a chronic or terminal illness
patient with either CHF, IPF, or lung cancer with high costs associated with frequent hospital
readmissions due to a lack of care planning or proper expectations of potential outcomes
following procedures such as an LVAD or cardiothoracic transplant.
If palliative care were to intervene earlier in these high-risk, high-cost patients’
diagnoses, the extra resources could be placed in improving their QOL and decrease costs,
allowing a return on investment (ROI) that palliative care provides. The average cost for one
night of treatment in an intensive care unit is $4000 (Winters, 2013). With palliative care onboarded, there is potential to minimize these admissions with advanced care planning. Tables 2-5
highlight the chance of hospital admissions with PC. The results are not significant. However,
clinical trials with PC are still novel, leaving promise for future growth.
Similar to a checklist at the time of diagnosis, several doctors trialed a pre-VAD
evaluation for patients in destination therapy (would use device until death) or those with bridge
to transplantation. The pre-VAD evaluation "aimed to test the feasibility of PC intervention to
elucidate patients’ goals and values in LVAD therapy in both destination therapy (DT) and
bridge to transplant (BTT)" ((Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman, 2017).
The palliative care evaluation was mandatory and addressed patient comfort, patient and family
understanding of LVAD therapy, patient goals and expectations, spiritual needs, possible
complications and unacceptable conditions, as well as decision making. After the evaluation,
family awareness of acceptable conditions for a patient increased from 33% to 58%, being
statistically significant, p< 0.01 ((Nakagawa, Yuzefpolskaya, Colombo, Naka, & Blinderman,
2017). Another study found similar results, finding that after a PC consultation, six patients
requested their resuscitation orders be changed from full code to DNR (Colman, Singer, Barua,
& Downar, 2015). Knowledge of effective palliative care routes made some patients realize their
goals could be achieved without life-prolonging measures and treatments. Facilities utilizing
palliative care on a regular basis report that integration of palliative care prior to ventricular
assist device placement can help prepare patients and families for the difficult process of
discontinuing VAD support (Colman, Singer, Barua, & Downar, 2015). These studies
demonstrate that early intervention through consultations and evaluations help patients identify
their desires in the face of illness as well as reduce emotional and financial stress as difficult
decisions arise later in the course of illness.
Destination with Early Palliative Care
Clinical trials implementing palliative care in the early stages of heart and lung disease
are scarce because the research is still new. The lack of education and push towards the treatment
imperative make it difficult for patients and physicians to accept palliative care, but the studies
that do integrate palliative care early in a patient's treatment plan are promising and show
statistical significance. The Palliative Care in Heart Failure (PAL-HF) clinical trial provided an
interdisciplinary palliative care intervention in advanced HF patients that consistently showed
greater benefits to QOL, anxiety, depression, and spiritual well-being compared to usual care
alone. A study performed in 2010 determined patients assigned to early PC had fewer depressive
symptoms (p=0.001) compared to standard care patients and the median survival was longer
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amongst PC patients as well (p=0.002) (Temel et al., 2010). Temel (2010) reports data in figure 4
indicating that early palliative care intervention increased life expectancy by an average of 3
months. Sidebottom (2014) found similar results in her study where QOL scores increased 12.92
points in the intervention compared to 8 points in the control group that did not receive PC
intervention (p<0.001) (Sidebottom, Jorgenson, Richards, Kirven, & Sillah, 2014). Symptom
burden between test subjects and controls also had statistical significance (p<0.001) (Sidebottom,
Jorgenson, Richards, Kirven, & Sillah, 2014). Kavalieratos (2017) reports findings from a 2015
trial that compared the impact of inpatient consultation by a palliative care team versus usual
care for patients hospitalized for acute HF. Data suggest statistically significant improvements
for patients receiving inpatient PC consultations, including QOL, symptom burden, and mood"
(Kavalieratos et al., 2017). Studies such as they indicate the benefit of integrating palliative care
early in a patient's diagnosis.
A common misconception about palliative care and symptom management include the
prescription of opioids and benzodiazepines for symptom management. Both physicians and lung
transplant candidates often avoid such medications due to concern that they may compromise a
patient's eligibility for transplant (Colman, Singer, Barua, & Downar, 2015). However, several
clinical trials determined that "there were no episodes of clinically important opioid toxicity or
respiratory depression, and there was a trend toward increased exertion during exercise sessions
post-opioid versus pre-opioid" (Colman, Singer, Barua, & Downar, 2015), suggesting that
opioids prescribed to alleviate symptoms may improve quality of life without compromising
transplant eligibility. From a retrospective cohort study, 8 lung transplant recipients (33%) comanaged with palliative care did not receive CPR at the time of death, as dictated by palliative
care planning (Colman, Singer, Barua, & Downar, 2014). Small details such as these may seem
insignificant. However, it is shown that when patient's wishes at the time of death were honored
the bereavement of family members was improved (Anderson et al., 2018). Family members are
able to reflect on their loved one's legacy and find solace in knowing their wishes were honored.
Although physicians are reluctant to integrate palliative care into their patient's care,
"heart failure/ transplant team physicians who requested assistance with symptom management,
clarification of goals of care, and end-of-life care, viewed PC integration as beneficial to the
patient. Improved efficiency of HF/ transplant team was reported" (Schwarz et al., 2012).
Palliative care consultations and intervention helped dying lung transplant patients avoid
aggressive care and the ICU environment at the end of life (Colman, Singer, Barua, & Downar,
2015). By limiting the number of ICU visits, family members decrease the excessive cost of
hospitalizations, as well as the uncertain stress hospitals place on families and patients. Palliative
care may seem to be an additional cost, but there is a return on investment when considering
unnecessary medical treatment. For example, "patients enrolled in Medicaid at 4 New York state
hospitals who received palliative care incurred $6,900 less in hospital costs than a matched group
receiving usual care (Center to Advance Palliative Care). Palliative care consultations in another
study done by CAPC resulted in reductions of $1,700 in direct costs per admission for live
discharges and $4,900 per admission when the patient died in the hospital (Morrison et al.,
2008). When the costs are extrapolated, the result is a saving of more than $1.3 million for a
small hospital, and $2.5 million for an average sized medical center. Cost analysis of early
palliative care integration is still underdeveloped with complex interactions between costs of care
and diagnosis (e.g. cancer/ non-cancer distinctions) but these numbers show promise towards
reducing costs in an aging population (Smith, Brick, O'Hara, & Normand, 2014). Integrating
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palliative care early may also reduce costs by reducing the number of hospital admissions.
Further research is required to determine exact cost savings.
Palliative care is designed to look at a patient in the most holistic sense with domains
currently categorized into the following groups: spiritual, social, psychological, physical, ethical,
cultural, end of life aspects. These categories focus on goals of care that best influence the
patient, family, and potentially the health care system with the reduction of costs and high-risk
patients within hospital settings. Potential lies in adding a financial and legacy/bereavement
domain to the field, as they are already goals that lie within the principles of palliative care. The
goal of integrating palliative care at an early stage encompasses these ideas and allows a smooth
transition through arguably the most daunting time in a patient's life. Palliative care aids in
allowing the dying process to seem more normal. Families are able to better prepare for death of
their loved one knowing their wishes were met, and a plan was in place. Palliative care focuses
on these ideals and the domains to improve the precision of patient-centered goals, symptom
management, and overall quality of life for the patient.
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Tables/ Figures

Key Finding:
This research confirms palliative care is a relative unknown among consumers.

Figure
1. Demonstrating
the waxingabout
and waning
of a heart
failure patient
There
is a clear
need to inform consumers
palliativecondition
care and provide
consumers
with a
definition
of palliative
care. Sheikh, & Groninger, 2017).
transplant
(Bayoumi,

awaiting a

Consumer Awareness About Palliative Care

Figure 2. Consumer Awareness About Palliative Care. Approximately 92% of consumers in the
health care industry either misunderstood, or did not understand the purpose of palliative care.
With greater education, the distinction between palliative care and hospice can be made and
quality of life of many could be improved (McInturff, Harrington, 2011).
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Figure 3. Suggested time to initiate palliative care and how palliative care will progress through
the remainder of the patient's life (Kirch, 2011).

Figure 4. Kaplan- Meier Estimates of Survival According to Study Group. Median estimates of survival
were as follows: 9.8 months in the entire sample (151 patients), 11.6 months in the group assigned to
early palliative care (77 patients), and 8.9 months in the standard care group (Temel et al, 2010).
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Figure 5. Symptoms experienced by patients diagnosed with a chronic or terminal illness that
may or may not be dying (Rome, Luminais, Bourgeois, & Blais, 2011).
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Table 1. Primary Palliative Care Versus Specialty Palliative Care for Patients with Heart Failure
and Their Families. Criteria for when to refer to primary palliative care versus specialty
palliative care (Kavalieratos et al., 2017).
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Table 2. Summary of Existing Trials of Inpatient Specialty Palliative Care in Heart Failure.
Results from previously performed clinical trials implementing PC in HF (Kavalieratos et al.,
2017).
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Table 3. Summary of Existing Trials of Outpatient Specialty Palliative Care in HF. (Kavalieratos
et al., 2017)
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Table 4. Summary of Existing Trials of Home-Based Specialty Palliative Care in HF.
(Kavalieratos et al., 2017)

Table 5. Summary of Existing Trials of Primary Palliative Care/Collaborative Care Models in
HF. (Kavalieratos et al., 2017)
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